PAIA Biotech

PAIA Biotech has developed a patented detection technology that uses special microplates for small-batch, high-throughput testing. These assays focus on the quantification of biotherapeutics and the screening of key quality attributes such as glycosylation and aggregation. PAIA's analytical technology allows researchers to miniaturize and automate workflows in cell line and upstream development, and by addressing quality-related parameters early in the process, it helps reduce cell line selection risks and optimize process conditions.